0000919574-20-004430.txt : 20200702
0000919574-20-004430.hdr.sgml : 20200702
20200702164819
ACCESSION NUMBER: 0000919574-20-004430
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200701
FILED AS OF DATE: 20200702
DATE AS OF CHANGE: 20200702
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Casdin Partners Master Fund, L.P.
CENTRAL INDEX KEY: 0001534265
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36362
FILM NUMBER: 201010261
BUSINESS ADDRESS:
STREET 1: WALKER HOUSE
STREET 2: 87 MARY STREET
CITY: GEORGE TOWN
STATE: E9
ZIP: KY1-9001
BUSINESS PHONE: 212.300.5575
MAIL ADDRESS:
STREET 1: WALKER HOUSE
STREET 2: 87 MARY STREET
CITY: GEORGE TOWN
STATE: E9
ZIP: KY1-9001
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Casdin Capital, LLC
CENTRAL INDEX KEY: 0001534261
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36362
FILM NUMBER: 201010262
BUSINESS ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS
STREET 2: SUITE 2600
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 212.300.5575
MAIL ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS
STREET 2: SUITE 2600
CITY: NEW YORK
STATE: NY
ZIP: 10019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Casdin Partners GP, LLC
CENTRAL INDEX KEY: 0001534260
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36362
FILM NUMBER: 201010263
BUSINESS ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS
STREET 2: SUITE 1140
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: 212.300.5575
MAIL ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS
STREET 2: SUITE 1140
CITY: NEW YORK
STATE: NY
ZIP: 10019
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Casdin Eli
CENTRAL INDEX KEY: 0001534264
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36362
FILM NUMBER: 201010264
MAIL ADDRESS:
STREET 1: 1350 AVENUE OF THE AMERICAS
STREET 2: SUITE 1140
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC
CENTRAL INDEX KEY: 0000834365
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 943076866
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
BUSINESS PHONE: 4254011400
MAIL ADDRESS:
STREET 1: 3303 MONTE VILLA PARKWAY
STREET 2: SUITE 310
CITY: BOTHELL
STATE: WA
ZIP: 98021
FORMER COMPANY:
FORMER CONFORMED NAME: BIOLIFE SOLUTION INC
DATE OF NAME CHANGE: 20030113
FORMER COMPANY:
FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0306
4
2020-07-01
0
0000834365
BIOLIFE SOLUTIONS INC
BLFS
0001534265
Casdin Partners Master Fund, L.P.
1350 AVENUE OF THE AMERICAS
SUITE 2600
NEW YORK
NY
10019
0
0
1
0
0001534261
Casdin Capital, LLC
1350 AVENUE OF THE AMERICAS
SUITE 2600
NEW YORK
NY
10019
0
0
1
0
0001534260
Casdin Partners GP, LLC
1350 AVENUE OF THE AMERICAS
SUITE 2600
NEW YORK
NY
10019
0
0
1
0
0001534264
Casdin Eli
1350 AVENUE OF THE AMERICAS
SUITE 2600
NEW YORK
NY
10019
0
0
1
0
Common Stock, par value $.001 per share
2020-07-01
4
P
0
685000
14.50
A
5534524
D
Common Stock, par value $.001 per share
2020-07-02
4
P
0
305583
14.50
A
5840107
D
The reported securities were purchased by Casdin Partners Master Fund, L.P. (the "Master Fund") in a private investment in public equity transaction with the issuer on July 1, 2020.
The securities are owned directly by the Master Fund and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC, the general partner of the Master Fund, and (ii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC.
On July 2, 2020, the Master Fund entered into a stock purchase agreement with a director of the issuer pursuant to which the Master Fund agreed to purchase the reported securities from such director for a purchase price equal to $14.50 per common stock.
Each Reporting Person disclaims beneficial ownership in the securities reported on this Form 4 except to the extent of its or his pecuniary interest, if any, therein, and this report shall not be deemed to be an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Casdin Partners Master Fund LP, By: Casdin Partners GP, LLC, its General Partner, By: /s/ Eli Casdin, Managing Member
2020-07-02
Casdin Capital, LLC, By: /s/ Eli Casdin, Managing Member
2020-07-02
Casdin Partners GP LLC, By: /s/ Eli Casdin, Managing Member
2020-07-02
/s/ Eli Casdin
2020-07-02